Akums Drugs and Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 03-Jul-2026.
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.8 pts less than Nifty Microcap 250 and 1.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Akums Drugs reported audited standalone FY26 results with revenue from operations of Rs 13,487.36 million and profit after tax of Rs 1,116.40 million, down from Rs 1,609.98 million in FY25. The Board declared a final dividend of Rs 1 per share (50%) and a special dividend of Rs 2 per share (100%) on face value of Rs 2 each, totaling Rs 3 per share, subject to shareholder approval at the 22nd AGM scheduled for July 10, 2026. The record date for dividend eligibility is fixed as July 3, 2026. Additionally, the HR President was replaced effective May 14, 2026. The auditors flagged an ongoing Income Tax Department search and seizure operation from January 2025 and subsequent show cause notices, with no material adjustments made to the financial statements as the impact remains unascertainable.
The dividend declaration totaling Rs 3 per share signals confidence in the company's cash position despite lower profitability. The ongoing tax investigation remains a watch item for investors. Shareholders on record as of July 3, 2026 will be eligible for the dividend payout.